Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of pancreatic cancer.
Ohno E, Hirooka Y, Kawashima H, Ishikawa T, Kanamori A, Ishikawa H, Sasaki Y, Nonogaki K, Hara K, Hashimoto S, Matsubara H, Hirai T, Sumi H, Sugimoto H, Goto H; NSPINAL study group. Ohno E, et al. Among authors: kanamori a. J Gastroenterol Hepatol. 2018 Jan;33(1):320-328. doi: 10.1111/jgh.13967. J Gastroenterol Hepatol. 2018. PMID: 28872701
Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer.
Kawashima H, Itoh A, Ohno E, Nakamura M, Miyahara R, Ohmiya N, Hara K, Kanamori A, Itoh T, Taki T, Hirai T, Hashimoto S, Takeda K, Goto H, Hirooka Y. Kawashima H, et al. Among authors: kanamori a. Cancer Chemother Pharmacol. 2011 Sep;68(3):677-83. doi: 10.1007/s00280-010-1531-6. Epub 2010 Dec 5. Cancer Chemother Pharmacol. 2011. PMID: 21132496
Randomized Phase II Study of Consecutive-Day versus Alternate-Day Treatment with S-1 as Second-Line Chemotherapy in Advanced Pancreatic Cancer.
Ishikawa T, Kawashima H, Ohno E, Matsubara H, Sasaki Y, Achiwa K, Kanamori A, Sumi H, Hirai T, Nonogaki K, Tsuzuki T, Kuroiwa M, Hattori M, Maruta S, Hiramatsu T, Ando M, Hashimoto S, Hirooka Y. Ishikawa T, et al. Among authors: kanamori a. Oncology. 2019;96(1):1-7. doi: 10.1159/000492388. Epub 2018 Oct 26. Oncology. 2019. PMID: 30368509 Clinical Trial.
Comparison of 8- and 10-mm diameter fully covered self-expandable metal stents: A multicenter prospective study in patients with distal malignant biliary obstruction.
Kawashima H, Hashimoto S, Ohno E, Ishikawa T, Morishima T, Matsubara H, Sugimoto H, Nonogaki K, Kanamori A, Hara K, Kuwahara T, Nakamura M, Miyahara R, Ishigami M, Ando M, Hirooka Y; Nagoya Biliary Stent Study (NABIS)-01 Group. Kawashima H, et al. Among authors: kanamori a. Dig Endosc. 2019 Jul;31(4):439-447. doi: 10.1111/den.13366. Epub 2019 Mar 29. Dig Endosc. 2019. PMID: 30714216
404 results